BROOKS

HealthcareDrug Manufacturers - Specialty & GenericMicro Cap
Brooks Laboratories Limited

Brooks Laboratories Limited, a Mumbai-based company incorporated in 2002, operates in the Healthcare sector as a Specialty & Generic Drug Manufacturer. It provides contract develop...

हिन्दी में

Brooks Laboratories Limited, 2002 में निगमित मुंबई स्थित कंपनी है, जो हेल्थकेयर क्षेत्र में स्पेशियल्टी और जेनेरिक ड्रग मैन्युफैक्चरर के रूप में काम करती है। यह फार्मास्युटिकल कंपन...

₹70.13+0.96%1D
Previous trading day close · Data updates after market close
1W: +29.3%
1M: +11.3%
6M: -2.1%
1Y: -46.4%
66/100
AverageResearch Score
Market Cap
₹216 Cr
Micro Cap
P/E Ratio
9.25
Below avg
P/B Ratio
2.32
Reasonable
ROE
-12.2%
Weak
ROCE
25.2%
Excellent
Debt / Equity
0.08
Low debt
Div. Yield
N/A
EV/EBITDA
8.65
Attractive
52W Low: ₹36.3Current: ₹70.1352W High: ₹138
At 33% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
78/100
Growth
Revenue, EPS, profit growth
60/100
Valuation
PE, PB, EV/EBITDA vs sector
70/100
Risk
Debt levels, volatility, coverage
60/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
9.25(Below avg)
Forward P/E
N/A
P/B Ratio
2.32(Reasonable)
P/S Ratio
2.15(Good)
EV/EBITDA
8.65(Attractive)
Dividend Yield
N/A
5Y CAGR
-3.1%(Moderate)
Revenue Growth
26.7%(High)
Profitability
ROE
-12.2%(Average)
ROCE
25.2%(Excellent)
ROA
-9.3%(Average)
Net Margin
23.3%(High)
EBITDA Margin
25.6%
Financial Health
Debt to Equity
0.08(Low debt)
Current Ratio
1.48(Tight)
Quick Ratio
1.08(Good)
Interest Coverage
30.26x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
65(Neutral)
RSI Exp (14)
75(Overbought)
MACD
0.165(Bullish)
MACD Signal
-1.107
BB Position
106%(Upper band)
BB Width
28.63%(High volatility)
ADX (14)
24.1(Weak trend)
Williams %R
-24.2(Neutral)
MFI (14)
90(Overbought)
CCI (20)
231(Overbought)
Stoch %K
76(Neutral)
ATR (14)
4.09(Avg True Range)
OBV (M)
3.1(Positive)
1W OBV Chg
457.5%(Increasing)
Rel Volume
15.27x(High activity)
Volatility
61.8%(High)
Max DD 1Y
-81.0%(High loss)
EMA 200
72.3
EMA 50
62.1
SMA 200
64.5
vs SMA 50
13.6%(Above SMA50)
vs SMA 200
8.6%(Above SMA200)
Volume
10.60L
Avg Vol 3M
0.7L
Shareholding Pattern
Promoter
52.6%
High confidence
FII
0.2%
DII / MF
10.4%
Share BROOKS
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.